Texture_linecircles.png
ABOUT US
abstract.png

Deverra Therapeutics, Inc. is a clinical stage biotechnology company located in Seattle, Washington dedicated to the development of allogeneic, off-the-shelf  universal donor cellular immunotherapies to make on demand treatment of patients with cancer and infectious diseases possible. 

Our innovative and well-established platform can be used to generate a range of unmodified and modified (engineered) progenitor and immune cells to boost the patient’s blood and immune system to eliminate cancer and virally infected cells. Deverra’s team includes pioneers who were first to demonstrate clinical effectiveness using expanded stem cell therapies and  non-HLA matched, universal donor off-the-shelf cell therapies.

Lab4a.jpg

The company has exclusive license to the proprietary Notch-mediated stem cell expansion and directed differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and multiple  clinical trials.

OUR MISSION

 Dedicated to developing allogeneic universal donor cellular immunotherapies that are cost effective and accessible to all patients in need

Video_still.jpg

OUR PARTNERS

ResearchPartners_FredHutch.png
ResearchPartners_sorrento.png
ResearchPartners_TwinStrand.png
ResearchPartners_NYBB.png

Research Partners

Cord Blood Bank Partners

ResearchPartners_NCBP.png
ResearchPartners_CCB.png